Dr Michael Winlo Archives | Page 5 of 6 | Cannabiz

Dr Michael Winlo

Emyria granted TGA approval for medical grade, smartphone-enabled, monitoring software

by Martin Lane May 13, 2021April 26, 2024

Emyria has received a Class IIa “software-as-a-medical-device” registration with the Therapeutic Goods Administration (TGA) for its […]

Emyria and Cann Group ink deal to fast track over-the-counter CBD registration

by Martin Lane March 29, 2021April 26, 2024

Emyria grows Emerald Clinics operation in Perth

by Martin Lane March 3, 2021April 26, 2024

Emyria hires global pharmaceutical expert to chair strategic advisory board

by Martin Lane February 23, 2021April 26, 2024

Emyria adds Emerald Clinics site

by Martin Lane February 10, 2021April 26, 2024

Cannabis will never be mainstream until we have evidence for drug registration

by Steve Jones January 14, 2021April 26, 2024

Dr Michael Winlo

Emyria to apply for TGA registration of anxiety, depression and stress treatment in 2021

by Martin Lane January 6, 2021April 26, 2024

Emyria’s IBS study attracts strong interest from patients

by Martin Lane December 4, 2020April 26, 2024

Neurotech International

Emyria and Zelira collaborate on clinical trial of Hope for autism patients

by Martin Lane November 10, 2020April 26, 2024

Emerald Clinics to rebrand as Emyria to reflect ‘global ambition’

by Steve Jones August 17, 2020April 22, 2024